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Abstract 
 Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that 
begins during childhood. Medication is currently the most common form of treatment for 
ADHD. Both stimulant and non-stimulant medications can be used to treat ADHD, but they both 
have side effects. The current review examines the effectiveness of omega-3 fatty acids, diet and 
nutrition and yoga as alternative interventions to medication for ADHD. A total of 15 studies 
were reviewed as five studies were reviewed for each intervention. The interventions of two 
studies were found to have significant positive effects on ADHD symptoms in support of using 
omega-3 fatty acids, and another two studies found significant results for changing diet and 
nutrition. All five studies reviewed on yoga were found to have significant positive effects on 
ADHD symptoms. Implications for schools and future directions are discussed. 
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ADHD Interventions as Alternatives or Supplemental to Medication 
Attention-Deficit/Hyperactivity Disorder is a neurodevelopmental disorder that starts 
during childhood (American Psychiatric Association, 2013). ADHD can be characterized by 
hyperactivity and impulsivity, inattention, or both. Medications is a common way to treat this 
disorder, but medications can have many side effects (AAP, 2016; DailyMed, 2018; Kelsey et 
al., 2004; National Institute of Mental Health, 2016; Subcommittee on Attention-
Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, 
2011; Wernicke et al., 2003). There are interventions proposed that do not involve medication or 
can be used with medication to achieve maximum treatment results. To examine such treatments, 
this literature review will examine the effectiveness of omega-3 fatty acids, diets without food 
additives, and yoga on ADHD symptoms. The review will examine which of these 
nonpharmacological treatments are effective and evaluate which could be helpful to families and 
school personnel. 
ADHD Definition 
  
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition defines ADHD 
as “a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
functioning or development” (American Psychiatric Association, 2013). The DSM-5 lists criteria 
for inattention and hyperactivity-impulsivity. Approximately 3-4% of children in the general 
population have ADHD, and it is a familial disorder (Thapar & Cooper, 2016). 
There are three presentations of ADHD (American Psychiatric Association, 2013). The first 
presentation, combined, occurs when sufficient criteria are met for both inattention and 
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hyperactivity-impulsivity. A predominantly inattentive presentation, the second type of 
presentation, occurs when sufficient criteria are met for inattention but not hyperactivity-
impulsivity. The third presentation, predominantly hyperactive/impulsive, occurs when sufficient 
criteria are met for hyperactivity-impulsivity but not inattention. According to the DSM-5, the 
criteria met are based	on	behavior	demonstrated	over	the	course	of	the	6	months	preceding	the	diagnosis. The DSM-5 lists nine criteria for both inattention and hyperactivity and 
impulsivity, and six of the nine criteria for at least one of the presentations must be met before 
the age of 12 for someone to be determined to have at least one of these presentations. Some 
examples of criteria for inattention are frequently losing supplies, having trouble organizing 
tasks, and frequently being forgetful in daily tasks. Examples of criteria for hyperactivity and 
impulsivity include fidgeting or tapping when sitting, excessive talking, and not being able to 
wait for one’s turn. Meeting criteria for the inattention presentation, hyperactivity and 
impulsivity presentation, or the combined presentation is only one component that is considered 
in ADHD diagnosis. In addition, many symptoms for at least one presentation must have been 
present before the age of twelve, exist in more than one environment, and must have a negative 
effect on social, academic, or occupational functioning. The symptoms also must be present 
outside of psychotic disorders and more direct links to other mental disorders do not exist 
(American Psychiatric Association, 2013). 
Gender Differences. The prevalence of ADHD presentations are not consistent across 
genders. ADHD is more prevalent in males than females (Thapar & Cooper, 2016). There are 
approximately two male children with ADHD for every one female child with ADHD 
(Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007). The percentage of boys diagnosed 
with ADHD at any point in life for children and adolescents ages 4 to 17 is 15.1%, and the 
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percentage of girls diagnosed with ADHD is 6.7% according to parent reports (Visser et al., 
2014).  Furthermore,	there	appear	to	be	differences	in	symptoms	between	male	and	female	children	with	ADHD. Males are more likely to display a hyperactive/impulsive presentation, 
while females are more likely to display a predominantly inattentive presentation (Zambo, 2008). 
It has also been found that females referred for ADHD may demonstrate more internalizing 
behaviors than females who do not have ADHD (Gaub & Carlson, 1997). 
Evaluation. To determine whether a child has ADHD, healthcare professionals should 
refer to the guidelines in the DSM-5 (Attention-Deficit/Hyperactivity Disorder (ADHD): 
Symptoms and diagnosis.). To gain an understanding of the child, they can examine reports from 
parents or guardians, teachers, and other school and mental health clinicians who play a role in 
caring for the child (Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering 
Committee on Quality Improvement and Management, 2011). Evaluations for ADHD can be 
conducted by primary care clinicians for children four to eighteen years old who have problems 
with academics or behaviors and show inattention, hyperactivity, or impulsivity (Subcommittee 
on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and 
Management, 2011). The clinician should also ensure there are no alternative causes, and they 
should assess the child for emotional, behavioral, developmental, and physical conditions that 
could exist along with ADHD or be the primary cause of presenting behaviors. 
According to Children and Adults with Attention-Deficit Hyperactivity Disorder 
(CHAAD), diagnosing ADHD should involve both an initial screening evaluation and a 
comprehensive evaluation for ADHD (The ADHD Diagnostic Process, 2018). The initial 
screening evaluation should start with an interview, and DSM-5 presentation criteria should be 
used to determine whether ADHD symptoms are present. The comprehensive evaluation for 
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ADHD should include in-depth interviews of both the individual and people who know the 
individual well, a bio-psycho-social assessment, ADHD behavior and self-report rating scales, 
scales completed by people who know the individual well, and referrals for assessments for other 
disorders. In addition, for children, a separate interview or play session should be held in order to 
discuss their behaviors with them or to observe their behaviors. Children should be observed in a 
place familiar to them if possible as well. For children, information about their behavior needs to 
be gathered from multiple people, so that there is information about the child in multiple settings 
for evaluation (Diagnosis in Children, 2018). The information gathered together should inform 
clinicians how ADHD can affect the child at home, at school, and in social functioning. 
Treatment 
As many as 17.5% of children with ADHD in 2011 were not receiving any treatment for 
ADHD (Visser et al., 2014). This is especially concerning since over one-third of these children 
had moderate or severe ADHD. Medication and behavior therapy are two common methods of 
treatment for ADHD in the United States, and the prevalence of each varies from state to state. 
Treatment for ADHD is important to help children focus in school and maintain greater control 
over their behavior. 
Medication. Medication is the most commonly used treatment for ADHD, specifically 
stimulants like methylphenidate (MPH) and mixed amphetamine salts (MAS) (De Sousa & 
Kalra, 2012). As of 2003, 4.3% of children ages 0 to 17 were prescribed ADHD medications, 
which was approximately 56% of children who had been diagnosed with ADHD at this time 
(Centers for Disease Control and Prevention, 2005). In the 2011 study by Visser et al., 83% of 
children and adolescents who had a history of ADHD had current ADHD, and ADHD 
medication was being used by 69% of these children and adolescents (Visser et al., 2014). The 
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parents reporting information in the study reported that of the children taking ADHD medication, 
8.4% were males and 3.7% were females. Visser et al. (2014) found a 27% increase from 2007 to 
2011 in the amount of children in the United States who were taking medication for ADHD. 
Types of medication and effectiveness. Children may be prescribed stimulant or non-
stimulant medications for ADHD. Stimulant medications for ADHD have varying forms of MPH 
and amphetamine. Dopamine levels in the brain, which are linked to attention, are increased by 
stimulants (De Sousa & Kalra, 2012). Two common stimulant medications with MPH are Ritalin 
and Concerta (National Institute on Drug Abuse, 2018).  Stimulants are more commonly 
prescribed for ADHD, but non-stimulants may be prescribed in a number of cases: when a 
person experiences troublesome side effects from stimulants, stimulants are not effective, or in 
addition to a stimulant for heightened effectiveness (National Institute of Mental Health, 2016). 
Treating ADHD with medication has been found to be generally effective (De Sousa & Kalra, 
2012). Doctors can work with patients to find a medication or medication combination that best 
fits the need of the patient. The side effects of stimulant medications for ADHD that children 
most often experience are loss of appetite, abdominal pain, headaches, and disturbed sleep 
(Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality 
Improvement and Management, 2011). Other side effects include tics, or sudden, repetitive 
movements or sounds; personality changes, and increased anxiety and irritability (National 
Institute of Mental Health, 2016). There are three non-stimulants approved by the FDA for 
ADHD treatment, which are Strattera (atomoxetine), Intuniv (guanfacine), and Kapvay 
(clonidine) (U.S. Food and Drug Administration, 2017). Side effects for Strattera for children 
include small, nonsignificant increases in blood pressure (Wernicke et al., 2003), less appetite 
(Kelsey et al., 2004), somnolence, and fatigue. Intuniv side effects include sleepiness, headaches, 
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irritability, dizziness and nausea (AAP, 2016). This medication typically does not cause 
significant suppression of appetite. Side effects of Kapvay when used as a monotherapy include 
somnolence, fatigue, irritability, nightmares, insomnia, constipation, and dry mouth (DailyMed, 
2018). When taken with a stimulant for ADHD, its side effects include somnolence, fatigue, 
decreased appetite, and dizziness.  
Medication protocol. Children’s primary care clinicians are most often responsible for 
prescribing treatment for ADHD after making a diagnosis (Subcommittee on Attention-
Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, 
2011). For 4-5-year old children, clinicians should implement evidence-based behavior therapy 
before prescribing medication. These behavior therapies can be carried out by parents and/or 
teachers. If the child’s function still exhibits moderate-to-severe continuing disturbance, the 
clinician can prescribe methylphenidate or non-stimulant medications for the child. If a child 
does not have access to evidence-based behavior therapy due to availability, their clinician needs 
to consider the implications of medication before prescribing it. For 6-11-year old children, it is 
preferred that clinicians prescribe both medications approved for ADHD by the U.S. Food and 
Drug Administration and evidence-based behavior therapy provided by parents and/or teachers. 
Clinicians can prescribe one or the other. When adolescents are 12-18 years old, clinicians 
should prescribe medication approved by the U.S. Food and Drug Administration after the 
guardian gives consent and the adolescent gives assent. When a clinician prescribes medication 
for ADHD, they should continue to adjust the doses for the child or adolescent so that the 
medication can provide maximum benefits and minimal side effects for the child or adolescent. 
Adjustments in dosage and the type of medication may be necessary because of changes in both 
physical and hormonal maturation. 
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Behavior therapy. Behavior therapy is a treatment that aims to help strengthen positive 
behaviors and extinguish behaviors that are problematic or unwanted (Treatment, 2017). It has 
been found that treatment that involves both medication and cognitive behavior therapy is more 
effective than treatment that only involves medication (Sprich, Safren, Finkelstein, Remmert, & 
Hammerness, 2016). Therapists work directly with children or with parents when using behavior 
therapy. Therapists help children replace problematic behaviors and express their feelings in 
ways that are not problematic in behavior therapy (Treatment, 2017). Parents can be trained in 
providing behavior therapy to their children by a therapist (Behavior therapy for young children 
with ADHD, 2017). In training, parents will gain skills in positive communication such as active 
listening, reinforcing good behavior, and providing consistent discipline. Behavior therapy can 
also take place in classrooms, as teachers and early childhood caregivers can learn how to use it 
(Treatment, 2017). The American Academy of Pediatrics (AAP) suggests that evidence-based 
behavior therapy provided by a parent or teacher should be the first treatment prescribed for 
children ages 4 to 5 for ADHD by their doctors (Subcommittee on Attention-
Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, 
2011).  
There are four models on which behavior therapy is frequently based, which are classical 
conditioning, operant conditioning, social learning theory, and cognitive behavior modification 
(Black & Bruce, 1989). According to the third volume of the Annual Review of Behavior 
Therapy Theory & Practice by Franks & Wilson (1975), the Association for Advancement of 
Behavior Therapy defines behavior therapy as the following: 
Behavior therapy involves primarily the application of principles derived from research 
  
in experimental and social psychology for the alleviation of human suffering and the 
  
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               11 
enhancement of human functioning. Behavior therapy emphasizes a systematic 
  
evaluation of the effectiveness of these applications. Behavior therapy involves 
  
environmental change and social interaction rather than the direct alteration of bodily 
  
processes by biological procedures. The aim is primarily educational. The techniques 
  
facilitate improved self-control. In the conduct of behavior therapy, a contractual 
  
agreement is usually negotiated, in which mutually agreeable goals and procedures are 
  
specified. Responsible practitioners using behavioral approaches are guided by generally 
  
accepted ethical principles. (p. 1-2) 
Behavior therapy and cognitive behavior therapy help people make changes and reach 
goals (Association for Behavioral and Cognitive Therapies). When behavior therapy or cognitive 
behavior therapy is implemented in treatment for people with ADHD, the target changes and 
goals may include a way of acting,  a way of feeling, a way of thinking, a way of dealing with 
physical or medical problems, or a way of coping (Association for Behavioral and Cognitive 
Therapies). 
Dietary supplements. Dietary supplements are thought to help treat ADHD, but only 
1.2% of Children with Special Health Care Needs (CSHCN) with ADHD use only dietary 
supplements to treat ADHD according to a study by Visser et al. (2015). In the past year, 10.2% 
of all CSHCN with ADHD were utilizing dietary supplements, meaning these children utilized 
dietary supplements in addition to medication and/or behavior therapy. When these children 
were twelve years old or older, they were less likely to take dietary supplements than those who 
were four or five years old. CSHCN more frequently take dietary supplements when they come 
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from a family with an income over 200% of the federal poverty level and have nonpublic 
insurance.  
Treatment differences among states. The prevalence of medication usage and behavior 
therapy as interventions for ADHD varies across the United States (Figure 1). Based on the 
results of the 2009-2010 NS-CSHCN, California is the state in which medication treatment is the 
least prevalent as 56.6% of CSHCN had taken medication for ADHD in the past week, and 
medication treatment was the most prevalent in Michigan, as 87.5% of CSHCN had taken 
medication for ADHD in the past week (Visser et al., 2015). Behavior therapy was found to be 
least common in Tennessee, with 32.5% of CSHCN having received behavior therapy in the past 
year, and most common in Hawaii, with 60.6% of CSHCN having received behavior therapy in 
the past year. On average, 74.0% of CSHCN with current ADHD as reported by parents, had 
taken medication for ADHD in the past week, and in the past year, behavior therapy was 
conducted with 44% of CSHCN with current ADHD. Both medication and behavior therapy 
were being administered to 30.7% of CSHCN who currently had ADHD.  
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Figure 1. This map from the CDC shows the percentages of children ages 4 to 17 with special 
health care needs who received medication for ADHD in the past week and behavioral therapy 
in the past year in each state. The map is based on data collected from July 2009 to March 2011 
as part of the National Survey of Children with Special Health Care Needs (Visser et al., 2015). 
When noting the years of the data included in this map, it is important to consider that it takes to 
gather data such as this to this extent.  
Current Review 
The purpose of this review is to examine the effectiveness interventions for children with 
ADHD, whether administered alone or with medication, through a literature review. 
Additionally, the implications of this review will examine potential of interventions to be used 
by caregivers and that school personnel can encourage or facilitate to help children with ADHD 
be less hyperactive and more attentive. According to an article on the Understood website that 
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does not cite peer-reviewed journal articles, the writer states that the interventions of exercise, 
going outside, omega supplements, mindfulness and changes in diet have been found to have 
somewhat of an impact on ADHD symptoms (Kelly). This page also says that vitamin, mineral 
and herbal supplements, melatonin, “train the brain” games, chiropractic care and lavender and 
other scents have not been found to be effective. This page offers this list of treatment, and this 
review will examine what recent research has found about some of these interventions. The 
current review will examine empirical research studies on various ADHD interventions 
regarding omega-3 fatty acids, diet and nutrition and yoga that can serve as alternatives to 
medication or can be used supplemental to medication in depth. These interventions are 
examined in the review since omega-3 fatty acids could be taken at school, diet and nutrition 
could be changed through school cafeterias and yoga exercise has the potential to be practiced at 
school. While the article from Understood claims research has not supported vitamin, mineral 
and herbal supplements, this study examines vitamin and mineral supplements as part of diet and 
nutrition due to the close associations vitamins and minerals have with diet.  
Methodology 
This research is a literature review of peer-reviewed journal articles that study omega-3 
fatty acids, diet and nutrition and yoga as interventions that can be used instead of or in 
conjunction with medication for ADHD. The literature review aimed to synthesize information 
about the effectiveness of each intervention. The journal articles were found using the following 
search engines: the UNC Library Homepage Search engine, Google Scholar, CINAHL, 
PsycInfo, and ERIC. Most of the searches were narrowed to only include studies from the past 
five years, 2013-2018, but some included the past seven years, 2011-2018. 
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 The following search terms were used in finding relevant articles: “ADHD yoga”, 
“ADHD predominant treatment”, “ADHD behavior therapy”, “ADHD behavioral therapy”, 
“ADHD and omega-3”, “ADHD and omega-3 fatty acids”, “preservatives and ADHD”, “ADHD 
caramel dye”, “ADHD elimination diet”, “ADHD and yoga”, and “ADHD and diet.” Articles 
were also found by reviewing the references of prior literature reviews.  
Literature Review 
Prior studies on interventions for children with ADHD involving omega-3 fatty acids, 
diet and nutrition, and yoga were reviewed for the current study. Five studies were reviewed for 
each type of intervention. 
Omega-3 Fatty Acids 
Cornu et al. (2018) completed a study on the effects of omega-3 supplements on children 
with signs of moderate ADHD through a double-blind placebo-controlled randomized trial in 
France. The 162 participants were children ages 6 to 15. All of the participants had an ADHD 
diagnosis based on the DSM-IV-TR criteria completed by child psychiatrists who are specialists 
in ADHD. Children were not eligible for the study if it was known they had an intolerance to 
omega-3 fatty acids, had taken fatty acid or fish oil dietary supplements more than one week in 
the 3 months prior to being accepted into the study, or had taken ADHD medication in the month 
prior to being admitted to the study. Randomization was used to assign participants to receive the 
docosahexaenoic acid-eicosapentaenoic acid (DHA-EPA) treatment or a placebo, and they 
received the treatment or placebo for 3 months. Participants received either capsules with the 
appropriate dosages for their ages of the EPA and DHA that contain vitamins A, D, and E or 
placebo capsules with olive oil, corresponding amounts of vitamins A, D, and E, and small 
amounts of marine lipid concentrate. To encourage the participants to take the capsules, 
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strawberry flavor was included in all capsules. The researchers counted pills to measure 
compliance. It was unknown to the participants, care providers, researchers assessing results, 
study coordinators, and monitors whether each participant received the placebo or nonplacebo 
pills. At the beginning of the study and each month following, the parents of participants 
responded to the Attention-Deficit Hyperactivity Disorder Rating Scale version IV (ADHD-RS-
IV). This scale contains eighteen items regarding ADHD symptoms that are rated on a 4-point 
scale. The study also utilized the Conners Parent Rating Scale (CPRS-R:L), a standardized test 
for reading in French, Attentional Performance Tests for Children (Kinder Test of Attentional 
Performance (KiTAP) for ages 6 to 10 and Test of Attentional Performance (TAP) for ages 11 to 
15), and The Children’s Depression Inventory. The changes between the scores of these 
secondary scales at the beginning of the study and after 3 months were included in assessment. 
The results of the study found that there was a greater improvement from the initial ADHD-RS-
IV scores related to the placebo pills than the supplement pills. This improvement with the 
placebo pills was significant (p=.039). The researchers acknowledged that the results may be due 
to their sample, as the initial scores of the ADHD-RS-IV suggest that the participants had mild to 
moderate ADHD and therefore may not benefit from the supplement given in the study. 
Barragán, Breuer & Döpfner (2017) completed a study to compare the effects of omega-3 
fatty acids and stimulants on ADHD symptoms in children in Mexico. Participants received 
Omega-3/6, the stimulant methylphenidate (MPH), or both for 12 months. Ninety of the 107 
patients that were screened were included in the study, and 30 participants were assigned to each 
treatment type. To be included in the study, participants had to be between the ages of 6 and 12, 
and they had to have a recent diagnosis of ADHD. Participants were excluded based on a number 
of factors including neurologic disorders, autism or pervasive developmental disorders, aknown 
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hypersensitivity to elements of omega-3/6, past ADHD treatment involving medication, 
persisting chronic conditions, medication for chronic conditions or not receiving assistance at 
school. The researchers conducted clinical assessments at five points during the study. Parents 
completed the Spanish version of the ADHD Rating Scale by DuPaul, Power, Anastopoulos, and 
Reid (1998) and both the parents and a researcher completed the Clinical Global Impressions-
Severity (CGI-S) scale. Randomization was used to assign participants to one of the three 
treatment groups. Results of the study showed that MPH treatment is slightly more effective than 
treatment with the Omega-3/6 fatty acids used in the study. Participants were able to take less 
MPH when they received the MPH and Omega 3/6 combined treatment, and participants 
receiving combined treatment may be more likely to comply with treatment than participants 
only receiving MPH. The results showed that this treatment was not more effective than 
treatment with only MPH, but the effectiveness of the combination treatment was shown to be 
significant (p=.007). Participants receiving combined treatment were able to take lower doses of 
MPH. Additionally, the results suggest stabilization of the three treatments could stabilize 
despite the slower increase of control and decrease in symptoms with Omega-3/6 and 
MPH+Omega 3/6 groups compared to the MPH group, based on the leveling off of scale scores 
around Week 8 of treatment. 
Milte et al. (2015) studied the effects of DHA and EPA in children with ADHD in 
Adelaide and Brisbane, Australia. The 90 participants in the study were 6 to 13 years old, and 
they either had an ADHD diagnosis or had symptoms greater than the 90th percentile on the 
CPRS and learning difficulties as reported by parents. Children could not participate in the study 
if they had used n-3 polyunsaturated fatty acid (PUFA) supplements in the past 3 months or if 
they were currently taking medication for ADHD. The study had three treatment conditions, with 
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the difference between the conditions being the order in which the participants received the 
different oils. The three oils in the study were an EPA-rich oil, a DHA-rich oil, and a control oil. 
The intervention was provided for 12 months, and each of the oils was consumed for 4 months. 
Randomization by minimization was used to assign the participants to a condition so that age and 
gender could be taken into consideration for the assignments. Three participants were excluded 
based on not reaching the criteria for ADHD to participate in the study, and 33 participants did 
not complete the study, leaving 54-57 participants to include in the statistical analyses for each 
oil. According to the researchers, taking blood samples of participants in studies involving 
interventions such as this one is important so that the participants’ degrees of compliance, 
especially with taking oil, can be measured. One limitation this particular study faced was 
sample size, as they did not obtain their target number of participants. The target number of 
participants was 120 because this sample size was estimated to allow for >80% power to find a 
medium effect size. The study found a significant positive associations on the ADHD Index 
(p=.030) and the Conners global scale (p=.028) with n-3 PUFAs. Improved outcomes were 
steadily predicted by decreasing the ratio of n-6:n-3.  
Milte et al. (2012) conducted a randomized controlled trial to examine how literacy and 
behavior of children with ADHD are impacted by an EPA-rich oil and a DHA-rich oil compared 
to a ω-6 PUFA—rich safflower oil, a linoleic acid (LA). There were 67 participants ages 6 to 13, 
all of whom had an ADHD diagnosis or demonstrated parent-rated symptoms greater than the 
90th percentile on the CPRS along with learning difficulties reported by the parents. Exclusion 
criteria included taking ω-3 PUFA supplements in the 3 months prior to the study. The 
participants could not be taking ADHD medication of any kind. Researchers conducted the study 
in Adelaide and Brisbane, Australia. At the beginning of the study, 90 participants took part in 
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baseline assessments and were assigned to a condition; EPA-rich oil, DHA-rich oil, or LA-rich 
oil. Everyone involved in the study was blinded to the treatment being received until data 
collection and analysis had been completed. A baseline and after 4 months, participants met with 
researchers to provide blood samples and complete cognitive assessments. Additionally, capsule 
containers were collected at the second visit in order to measure compliance through capsule 
counting. Various tests were used in the assessments involved in this study. To assess literacy, 
the Wechsler Individual Assessment Test III subtests for word reading and spelling were used. 
To assess performance, the Wechsler Scale of Children’s Intelligence III vocabulary subtest was 
used. A shortened test battery from the Test of Everyday Attention for Children including Sky 
Search, Score!, and Creature Counting was utilized to examine various forms of attention. A 
go/no-go task on computers was used to measure inhibition. The CPRS was used to collect data 
on ADHD symptoms, and questionnaires were used to gather demographic information. The 
blood samples provided were used to examine proportions of singular fatty acids in erythrocyte 
phospholipids. Of the 90 participants, 70 completed both visits, and three were excluded from 
analyses due to a lack of an ADHD diagnosis or ADHD severity scores lower than the study 
required. There was no significant difference between EPA and LA (p=.38) or between DHA and 
LA (p=.39) for ADHD index. While the researchers did not find any significant treatment effects 
related to the EPA or DHA-rich supplements in comparison to the control, they did find that a 
higher erythrocyte DHA over 4 months was associated with improvements in word reading and 
and oppositional behavior and that EPA and ω-3 PUFA levels were associated with less 
anxiety/shyness. 
A 2018 study by Crippa et al. also examined the effects of Omega-3 fatty acids on 
ADHD. The 48 participants were ages 7 to 14 and had an ADHD diagnosis. The participants 
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could not have taken ADHD medication or omega-3/omega-6 supplements during the 3 months 
before recruitment occurred. This study examined the effects of DHA on ADHD in children in 
Italy through a randomized, placebo-controlled, double-blind intervention trial. Participants were 
assigned to receive either the supplement or the placebo. The supplement was 500 milligrams of 
algal DHA given through two soft gelatin pearls each day. The placebo was also given through 
two soft gelatin pearls, but they contained 500 miligrams of wheat germ oil and a low 
concentration of Vitamin E. They received treatment for 6 months, and they were assessed at 
baseline, 4 months, and 6 months. Six months was chosen as the treatment duration because it 
can take as many as 3 months for long-chain PUFA levels in the brain to recover from a 
shortage. During the first visit, blood samples and weekly frequency of fish consumption were 
collected, participants completed the Pubertal Development Scale, and socioeconomic status was 
measured using the Hollingshead 9-point scale for parental occupation. During all visits, height, 
weight, and blood pressure were measured, participants were assessed through a selection of 
cognitive tests, parents completed a behavioral scale, and researchers completed a clinical rating 
scale. Parents had an additional responsibility of picking up the treatment supply each month. 
Researchers monitored compliance by weighing the unused treatment supply products that 
parents returned each month. The researchers determined compliance meant the participants took 
over 70% of the capsules they received. In addition to blood tests, the researchers and clinicians 
utilized the ADHD-RS-IV, the CPRS-Revised, the Strengths and Difficulties Questionnaire 
(SDQ), The Child Health Questionnaire (CHQ), the Clinical Global Impression—severity scale 
(CGI), the Children’s Global Assessment Scale (C-GAS), and a selection of cognitive tests from 
the Amsterdam Neuropsychological Tasks (ANT). When the treatment groups were compared, 
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no significant difference on the ADHD-RS-IV was found (p>.05). The CPRS also did not show 
significant improvements on ADHD symptoms.  
Diet and Nutrition 
A total of five studies were reviewed that examined the effects of diet and nutritional 
changes on ADHD symptoms in children. The diets examined considered food additives and a 
preservative, healthy and unhealthy foods, a restricted elimination diet and dietary patterns. 
Another study examined a vitamin-mineral treatment. 
One aspect of diet that has been speculated to be related to ADHD symptoms is food 
additives. Lok et al. (2013) researched how artificial food colorings and a preservative impact 
ADHD symptoms in eight- and nine-year-old children in Hong Kong over approximately 7 
months. Instead of focusing specifically on ADHD, the researchers chose to examine how food 
coloring and preservative can affect behavior. The study used methods of measurement used in 
ADHD research. To be included in the study, participants could not currently be taking 
medication to treat ADHD. Participants were not eligible for the study if they had diabetes, 
phenylketonuria, or other mental problems such as learning disabilities. The design of the study 
was a randomized, double-blind, placebo control trial. The study also had a within-subjects 
design, and the participants received AFC, the preservative sodium benzoate, and a lactose 
placebo in various orders. There were six sequences that participants could receive. In the first 
week of the study, the participants remained on their normal diets. In the following six weeks, 
the AFCs and preservative used in the study were absent from participants’ diets. In weeks two, 
four, and six, the participants received the placebo, AFCs, or sodium benzoate. In weeks one, 
three, and five, all participants received the placebo. Parents of the participants completed a 
questionnaire each week, and they participated in a phone call 3 months after the 6 week trial in 
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which researchers determined whether the study caused parents to keep their children on diets 
without additives. The researchers had parents and teachers complete the strengths and 
weaknesses of ADHD symptoms and normal behaviors (SWAN), and they had teachers 
complete the child behavior checklist (CBCL) as well. After running linear mixed-model 
methods and an analysis of variance for multiple comparison, results showed that there was not a 
significant increase of strengths or weaknesses associated with ADHD related to AFCs (effect 
size .07 for CBCL-TRF, .01 for SWANPT) and a sodium benzoate preservative (effect size .04 
for CBCL-TRF, .17 for SWANPT). The researchers acknowledged multiple limitations of the 
study, including a small effect size, the sample was not representative of the Hong Kong 
population, and parents could not easily constantly monitor their children’s diets. Furthermore, 
as the participants of this study did not have ADHD, the researchers suggest that future studies 
compare the effects of food colorings and preservatives among children with and without 
ADHD. 
Ghanizadeh and Haddad (2015) studied whether dietary intake affects Iranian children 
with ADHD. The researchers examined whether ADHD symptoms can be influenced by 
healthier and unhealthier foods. The study included 85 participants ages 5 to 14. The participants 
were required to have an ADHD diagnosis, and all children received MPH as part of the study. 
Random assignment was used to place participants in either the control group or experimental 
group. The control group only received MPH, and the experimental group received MPH and a 
list of “favored and unfavored” foods which was explained to the parents of the participants. 
Both treatments were one month in duration.  The favored foods included healthier foods such as 
vegetables and low-fat meat, and the unfavored foods included less healthy options such as soft 
drinks and sauces. The parents reported participants’ dietary intake for the past month through a 
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food frequency questionnaire. Participants completed assessments at baseline and after one 
month of treatment. The ADHD checklist was used to examine ADHD severity, and the 
researchers measured the weight, height, and body mass index of the participants. After losing 21 
participants to medication refusal or no responses to phone calls, the researchers examined data 
from 85 participants. The results show no significant association between the favored diet and 
hyperactivity/impulsivity in regard to hyperactivity/impulsivity either during or at the end of the 
trial (p=.2, p=.5, respectively). There was a significant association between the favored diet and 
inattentiveness (p<.0001).  
A study by Pelsser et al. (2011) examined whether a restricted elimination diet can 
contribute to behavioral improvements in children with ADHD. Children were recruited in both 
the Netherlands and Belgium. To be eligible for the study, children needed to be diagnosed with 
ADHD, be four to eight years old, and have parents with sufficient knowledge of Dutch who 
were willing to complete a 5-week restricted elimination diet. Children could not be included in 
the study if they were taking ADHD medication, receiving behavior therapy, already following a 
diet or had family situations that could hinder them from finishing the study. For the first of the 
two phases of the study, participants were assigned to the diet group or the control group through 
random sampling. Parents and teachers of the participants and the researcher who provided 
parents and teachers with advice during the treatment could not be masked to the group 
assignment since there could not be a reliable placebo diet. The second phase consisted of a 
double-blind crossover food challenge phase within the diet group. Four questionnaires were 
used in the study. The questionnaires used were the ADHD rating scale (ARS), the ten-item 
abbreviated Conners’ scale (ACS), the SDQ, and the SPI. Randomization occurred after 
participants had completed baseline assessments, and for 2 weeks parents did not change their 
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child’s diet and this time served as a baseline period. The parents recorded their child’s diet, 
behavior, activities, physical complaints and medications. After the 2 weeks, the parents 
completed the ACS and ARS again, and both parents and teachers completed the SDQ. The first 
phase of the study started during the fourth week. At this time, the diet group began a 5-week 
restricted elimination diet. The restricted elimination diets were individually designed. At first, 
participants followed the few foods diet that includes foods such as rice, meat, vegetables, pears 
and water, along with specific foods selected by the researchers including potatoes, fruits and 
wheat. The researchers wanted to make the elimination diet easy for parents and participants to 
follow, and if there were no reported behavioral changes from parents after the second week of 
the diet, parents gradually transitioned their child to the few-foods diet alone. After the 5-week 
intervention, the study pediatrician completed the ARS and SPI, parents and teachers completed 
the ACS, ARS, SPI and SDQ, and blood samples were taken from the participants. The second 
phase of the study included participants from the diet group in the first phase whose behavioral 
improvements were at least 40% on the ARS. These participants could be considered clinical 
responders. Blood samples from the first week of the first phase of the study were used to 
examine IgE and IgG levels. The assay technique ELISA was used to measure total IgE, food-
specific IgE to seven foods, and food-specific IgG to 270 foods. Foods were determined to be 
high IgG or low IgG through measurements with the ImuPro test, a certified IgG-specific food 
screening test. During the second phase of the study, the participants had two groups of food 
added to their diet which had three foods high in IgG or three foods low in IgG. These foods 
were added to the restricted elimination diet consecutively, and each was added to the diet for 2 
weeks. A dietician selected foods for each participant. After each food challenge group, parents 
completed the ACS and ARS. If there was a relapse in behavior in participants during the first 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               25 
food challenge, the SDQ and SPI were completed again during the eleventh or thirteenth week of 
the study. Participants only immediately completed the second food challenge if there was not a 
behavior relapse during the first. Both groups had blood taken at the thirteenth week. Participants 
who had behavior relapses during the first food challenge began the second after a washout 
period. It was determined that participants experienced a behavior relapse if their ARS score 
increased at least 40% at the end of the first phase and at least 60% from the baseline. As for the 
control group, these participants followed the first phase for the 13 weeks. Parents of these 
participants completed extended diaries, measurements were completed at similar times to the 
other group, and a second blood sample was taken during the thirteenth week. After this blood 
sample was taken, parents could begin the diet with their children if they did not demonstrate 
behavioral improvements during the study. The results supported that this diet can improve 
behavior in children with ADHD. Both the pediatrician and teacher ratings had mean differences 
on the ARS significantly lower in the diet group than the control group between baseline and the 
end of the first phase of the study (p<00.0001; p<00.0001, respectively). Parent and teacher 
scores on the ACS were also significantly lower in the diet group than the control group between 
baseline and the first phase (p<00.0001; p<00.0001, respectively). No significant effects of 
IgG or challenge period were found (p=075; p=026, respectively).  
Rucklidge, Darling, Eggleston, Johnstone and Frampton (2018) examined whether 
vitamin-mineral treatment can improve particular ADHD symptoms in children with ADHD. 
Ninety-three participants completed the study. The participants were children ages 7 to 12, and 
they had to meet the researchers criteria for ADHD. The researchers determined that to be 
included in the study, children had to meet the standards for ADHD based on the Kiddie 
Schedule for Affective Disorders and Schizophrenia Lifetime Version (K-SADS-PL) (Kaufman 
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et al., 1997) and parent and teacher Conners Rating Scales (CRS-R:L) (Conners, 1997). 
Furthermore, a registered clinical psychologist reviewed outcomes for each child and discussed 
diagnoses with the researchers. The study had a psychiatrist that participants met with as well. 
The CGI severity scale was used to give children a rating for severity of illness. Further study 
inclusion criteria was that participants could not have taken psychiatric medication in the past 4 
weeks, and participants needed to have the ability to take as many as 15 capsules per day with 
food. If participants were unable to easily swallow a pill, they completed a pill swallowing 
program by Kaplan et al. (2010). This program allowed 18 children to participate in the study. 
The researchers permitted participants to continue psychological therapies and supplements as 
long as there was consistency in the frequency and dosage for the entire study, and researchers 
typically permitted medications for physical conditions. Children were excluded from the study 
if their estimated IQ was under 75 based on vocabulary and block design subtests of the 
Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV) or educational assessments 
they had taken before, were on the autism spectrum, had epilepsy, could be hospitalized due to a 
significant psychiatric condition, had a serious medical condition, were allergic to ingredients 
used as part of the study or had an abnormal mineral metabolism. Two children were allowed to 
take part in the study with estimated IQ between 70 and 75 since accurate estimates could have 
been hindered by their ADHD symptoms. Many scales were used in the study. Participants met 
with a clinical psychologist or a psychology graduate student who was supervised by a 
psychologist seven times throughout the study either in person or over the phone. These seven 
contacts occurred at screening for the study, baseline, 2 weeks, 4 weeks, 6 weeks and 10 weeks, 
which was the end of the study. Two of the scales used that involved the clinician were 
completed during each contact, which were the CGI improvement scale and the C-GAS. The 
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CGI improvement scale considered responses from parents, information from teachers and the 
participants’ behavior in the clinic, and the C-GAS was completed by the clinician. The clinical 
version of the ADHD-RS-IV was completed by the clinician at baseline and the end of the study. 
Parents completed the Child Mania Rating Scale, Parent Version (CMRS-P) during each contact 
to provide data related to emotional dysregulation. At the beginning and end of the study, parents 
responded to the CPRS-R:L and the SDQ. Researchers also gathered information from parents at 
the beginning and end of the study on their child’s diet. Teachers were asked by parents to 
complete and mail the CTRS-R, the SDQ-teacher, and the Behavior Rating Inventory of 
Executive Function (BRIEF-teacher form) before the start of the intervention and 2 weeks before 
the intervention ended. Children had a scale they responded to after each contact. They 
responded to the Measure Yourself Medical Outcome Profile (MYMOP) to rate their own 
symptoms. Participants were randomized via a computer sequence to either the control group or 
the experimental group. The control group received a placebo while the experimental group 
received micronutrients. Forty-six participants received the placebo, and 47 participants received 
the micronutrients. Two participants in each group did not complete the study. All of the 
medications necessary for the duration of the study were put into kits by a pharmacist, and they 
had extra medication in case of a missed appointment or increased dosage. Additionally, a bottle 
of pills was provided at each assessment. During the first week of the intervention, the 
participants gradually increased from taking three pills per day to 12 pills per day. Participants 
began taking 15 pills per day after the fourth week of the study if they were not showing 
improved CGI improvement scale scores. The placebo and micronutrients appeared the same, as 
the placebo included riboflavin to make it smell and look similar to a vitamin. In an effort to 
measure compliance, the researchers collected unused pills. The results of the study showed no 
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significant differences in ADHD ratings between the placebo and micronutrients groups on either 
the ADHD-RS-IV completed by the clinician (p=.415) or the CPRS-R:L completed by parents 
(p=.540). Furthermore, while there was a clinically meaningful change in ADHD scores based on 
the numbers of participants in the placebo group and the micronutrients group showing a 30% 
decline on the ADHD-RS-IV, the change in ADHD scores was not significant (p=.08). When a 
post hoc analysis was performed of the ADHD-RS-IV subscales, there was a significant 
difference in improvement of inattentive symptoms in the micronutrients group compared to the 
placebo group (p=.005), but there was not a difference in the groups for 
hyperactivity/impulsivity (p=.951).  
Zhou et al. (2016) studied whether dietary and nutrient patterns can impact children with 
ADHD. The study included 592 participants, all of whom were Chinese children ages 6 to 14. 
The study utilized a matched-case control design, therefore, not all participants had ADHD. The 
children in the ADHD group were required to have an ADHD diagnosis from a board-certified 
child psychiatrist. Factors that could exclude children from the ADHD group are signs of autism, 
Asperger syndrome, epilepsy or a primary diagnosis of schizophrenia, identifiable prenatal 
insults, affective disorder, pervasive developmental disorder, or mental retardation. It is not 
stated whether the children could have been taking or currently take ADHD medication to 
participate in the study. A pair-matched design was used to construct the control group. Members 
of the control group were randomly selected at the clinics where diagnoses of ADHD occurred. 
Members of the control group aligned with the exclusion criteria for the ADHD group, had the 
same sex as a member of the ADHD group, and had the same age within 6 months as a member 
of the ADHD group. Parents of participants in both groups were interviewed by current 
epidemiology graduate students to provide the researchers demographic information and other 
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information regarding the children such as family structure, home environment, medical and 
educational histories of the participants and dietary habits one year before diagnosis or interview. 
The BMI of each participant was found as well following standards of the World Health 
Organization (WHO). A food frequency questionnaire (FFQ) was used to examine dietary intake 
in which 144 foods often consumed by Chinese children were listed and parents chose frequency 
categories to report how often their child had consumed each item in the past year. The Chinese 
Standard Food Composition Table was used to calculate participants’ average nutrient daily 
intake and total energy. The researchers also collected blood samples. A pair-match design was 
used in the study based on age and sex due to differences in these factors related to ADHD. In 
order to examine the relationship between dietary and nutrient patterns and ADHD, conditional 
logistic regressions were utilized. Four dietary patterns were analyzed, and it was found that 
32.50% of food intake variance could be attributed to these patterns. The four patterns were 
“vegetable-fruit”, “fish-white meat”, “grain-bean” and “fast food-sweet” (p. 357).   The only 
dietary patterns found to have significant inverse relationships with risk of ADHD were the fish-
white meat dietary pattern (p=.003) and the grain-bean dietary pattern (p=.018). Then, when 
controlling for possible confounding factors, only the fish-white meat dietary pattern was 
significantly negatively correlated with risk of ADHD (p=.006). Conditional logistic regression 
was also used to examine relationships between blood element levels and ADHD. Blood zinc 
concentration was found to have a significant negative correlation with risk of ADHD both 
before and after controlling for possible confounding variables (p=.005 and p=.008, 
respectively). 
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Yoga 
Yoga has also been studied in relation to ADHD symptoms. Chou & Huang (2017) 
conducted one study regarding yoga as an ADHD intervention that took place in Taiwan. The 
study had 50 participants with ADHD between the ages of 8 and 12. The participants were 
required to have an ADHD diagnosis. Children were not eligible to participate in the study if 
they also had conditions such as conduct/oppositional defiant disorder, ASD, or serious affective 
disorders. Additional exclusion criteria was that children could not have previously had brain 
injuries or neurological disorders, and they could not currently be taking sedatives or other 
medications that affect mood other than stimulants for ADHD. Half of the participants were in 
the experimental group that attended two 40-minute yoga sessions after school twice a week. A 
nationally certified yoga instructor led each session, and the structure of the sessions was based 
on the guidelines for working with children from the American Physical Therapy Association. 
The other half of the participants were in the control group and told to not engage in organized 
routine physical activity. Before the start and after the completion of the yoga sessions, the 
researchers administered the Visual Pursuit Test of the Vienna Test system (Schuhfried GmbH, 
Austria) and the Determination Test as used by Shmygalev et al. (2011). The researchers also 
approximated each participant’s physical fitness through methods such as a sit and reach test and 
a timed half-mile run. Independent t-tests and chi-square tests were used to compare the 
demographics of the experimental and control groups. Through mixed design ANOVAS, the 
study found that yoga can benefit children with ADHD. The accuracy of the yoga group on the 
Visual Pursuit Test was found to be higher at the post-test than that of the control group when the 
interaction of group by time was examined (p=.010). A group by time interaction was also 
examined for reaction time on the Visual Pursuit Test, and at the post-test it was found that the 
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yoga group had faster reaction times than the control group (p<.001). Furthermore, there were 
differences between the groups in their outcomes on the Determination Test. There was 
significantly greater accuracy on the post-test in the yoga group than the control group (p<.001). 
Like on the Visual Pursuit Test, the yoga group showed significantly faster reaction times than 
the control group (p=.034) on the Determination Test after the intervention.  ADHD symptoms 
that yoga can aid in improvement include attention, discrimination ability, and reaction time and 
response accuracy on the Visual Pursuit Test and the Determination Test. These results coincide 
with previous research. 
A study by Mehta et al. (2011) researched the effects on ADHD symptoms of a program 
including yoga postures, meditation, and behavioral play therapy led by high school volunteers. 
There were 76 participants in the study who were all in the age range of 6 to 11 years old and 
had an ADHD diagnosis. It is not stated whether participants could currently be taking ADHD 
medication. The study took place in India, and the participants were from urban or semiurban 
areas. The Initial Teacher Vanderbilt Assessment, translated into Hindi, was used in evaluating 
each child for ADHD. For 6 weeks, the participants had two 1-hour sessions per week that 
consisted of yoga postures, a meditation program, and behavioral play therapy. The sessions 
were held during the school day, and the participants completed the sessions in groups of 8-12 
students of the same gender. As the participants completed the sessions, the teachers supervised 
and used a scale to rat the behavior of the participants. The high school volunteers who led the 
program were trained in all aspects of the program and began leading the program after 5 weeks. 
The researchers assessed participants’ yoga performance through a yoga posture score, and they 
used recordings of participants’ breathing to assess their ability to complete the breathing 
component of meditation. Parents and teachers responded to Vanderbilt questionnaires. Of the 
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participants, there were 63 whose parents and teachers completed follow-up Vanderbilt 
questionnaires and for whom yoga posture scores (YPSs) were completed. The results of the 
study showed that there were academic and behavioral improvements in over half of the 
participants who participated in yoga. There was a significant decline in average performance 
impairment on the teacher and parent Vanderbilt assessments on the follow-up compared to 
baseline (p<.001). The average YPS improvement rate was 73.9% with a standard deviation of 
15.5. The YPSs improvement was similar for males and females and across ADHD subtypes. 
This study is interesting as the program was executed by older students. Since it was led by older 
students and had positive results, yoga could be a reasonable intervention for ADHD provided by 
schools. 
More recently, Cohen et al. (2018) studied the impact yoga can have on ADHD 
symptoms in preschool-aged children in California. The 23 children who participated in the 
study ranged from 3 to 5 years old and exhibited a minimum of 4 ADHD symptoms based on 
ADHD RS-IV Preschool Version. This criteria was chosen instead of an ADHD diagnosis 
because ADHD is typically not diagnosed in preschoolers. Two participants did have ADHD 
diagnoses, and one participant was taking ADHD medication. Parents and teachers of the 
participants completed the ADHD RS-IV Preschool Version so that the researchers could assess 
the ADHD symptoms of the participants. All of the participants were students at an urban, 
community-based preschool. The design of the study was a mixed-methods, randomized waitlist-
controlled trial. The intervention involved children’s yoga that was conducted with the 
participants both at home and at school, and the duration of the intervention was 6 weeks. At 
school, the participants had yoga in a room in the school that was not their classrooms. At home, 
the participants followed a DVD to complete their yoga exercises as their parents supported 
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them. The intervention was carried out across 12 weeks, because one group participated in the 
yoga intervention for the first 6 weeks, and the other group, the waitlist control, participated in 
the yoga intervention for the second 6 weeks. During the weeks that each group was not 
participating in the yoga intervention, they experienced no exposure to yoga. The researchers 
assessed behavioral ADHD symptoms of the participants using ADHD RS-IV Preschool Version 
and the SDQ and attention of the participants through computer-based tasks of the KiTAP. These 
tests were completed at the start of the study as a baseline measurement, after the first group 
finished the yoga intervention, after the second group finished the yoga intervention, and 3 
months after the second group finished the yoga intervention. In addition to these measurements, 
following each yoga intervention, the researchers utilized questionnaires, focus groups, and 
interviews with parents, teachers, and yoga instructors in order to collect qualitative data. After 
Group 1 received yoga exposure but Group 2 had not yet received yoga exposure, participants in 
Group 1 with a baseline score of 8.5 on the SDQ hyperactive-inattentive scale completed by 
parents had ratings two points lower on average than children in Group 2 who started at similar 
scores (p=.04). Group 1 participants who started with ADHD inattention ratings of 17 showed 
ratings four points lower at this same check-in than children in Group 2 who started at similar 
scores (p=.02). After Group 2 completed the yoga intervention, their total-scores on the SDQ 
rated their parents significantly decreased (p=.002). Their scores on the ADHD-RS-IV 
hyperactivity subscale as rated by parents significantly increased (p=.03). Overall, it is suggested 
by the study results that yoga leads to improvements for children with higher baseline ratings of 
ADHD symptoms in parent ratings of inattention and combined symptoms.  It is not suggested 
by the results that these ratings improve for the study group overall or that teacher ratings 
improve when children practice yoga. A small sample size and short intervention period were 
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among the limitations of this study. Furthermore, was found that the participants of this study 
only practiced yoga about half of the possible days, and no parents reported that participants 
continued yoga following their intervention period of the study. 
Hariprasad, Arasappa, Varambally, Srinath and Gangadhar (2013) also examined the 
effects of yoga on children with ADHD. More specifically, this study examined whether yoga is 
a reasonable and effective intervention to use in conjunction with in-patient care for ADHD. This 
study was conducted in India. There were nine participants ages 6 to 13, and they all had an 
ADHD diagnosis based on the DSM-IV confirmed by a child psychiatrist. All of the participants 
were receiving in-patient services in the child and adolescent psychiatry ward of the National 
Institute of Mental Health and Neurosciences. They could be taking medication while 
participating in the study, as all of the participants were receiving medication and/or behavioral 
interventions in the child and adolescent psychiatry ward. Researchers received written consent 
from the caregivers of the children, and, if possible, assent from the participants. Children were 
not eligible for the study if they had comorbid substance abuse or dependence, psychosis, 
suicidal and self-injurious behavior, moderate mental retardation, severe physical ailments like 
congenital heart disease, fracture or a seizure in the prior month. Children were also not eligible 
to participate in the study if their caregiver had any conditions that would inhibit them from 
practicing yoga. The participants were rated five times by a research associate on the ADHD-RS-
IV, Conners’ Abbreviated Rating Scale (CARS) and CGI. These ratings occurred at the start of 
the study and discharge, and after first, second and third months of follow-up. A yoga 
performance questionnaire was created by a yoga instructor for the study. The purpose of the 
scale was to rate the performances of the participants during yoga sessions. The questionnaire 
had 20 items, and it was completed by a yoga instructor after one week of the yoga intervention 
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and when the participant was discharged from the ward. A publication entitled “yoga in 
education” was used to create the yoga intervention used in the study. Aspects of yoga included 
by the researchers were loosening exercises, physical postures, breathing exercises and OM 
chanting meditation. A certified yoga instructor with at least two years of experience trained the 
participants and their caregivers in the selected yoga practices each day of the period of 
admission in the child and adolescent psychiatry ward of the National Institute of Mental Health 
and Neurosciences. Ideally, the caregivers participated in yoga, but they were at least trained in 
supervising the child as they practiced yoga. An additional responsibility of the caregivers was to 
record attendance and the amount of days that participants practiced yoga after being discharged. 
The yoga instructor provided at least six one-hour training sessions for each participant and 
caregiver. While the participants were in the child and adolescent psychiatry ward, they practiced 
yoga a minimum of eight days. Between baseline and discharge, there were significant decreases 
in scores on the CARS (p=.014), the ADHD-RS-IV (p=.021) and the CGI (p=.004).  
A qualitative study on a yoga intervention by Beart & Lessing (2013) was also reviewed 
for this study. This instrumental case study was conducted in a school for learners who have 
difficulties with learning in South Africa. The researchers chose to examine the impact of yoga 
on ADHD symptoms in children through the perceptions of parents, teachers, and children. The 
symptoms examined were anxiety, concentration, aggression and self-esteem. Ten children ages 
9 and 10 took part in the study. All of the participants had an ADHD diagnosis from a 
pediatrician. Participants were allowed to take medication during the study. Six of the 
participants were taking Ritalin, two were taking Concerta and two were not taking stimulants or 
non-stimulants for ADHD. One of the participants who was not taking stimulants or non-
stimulants for ADHD was taking Eye-Q and Scott’s Emulsion capsules. Eye-Q is an omega 
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supplement (Eye q), and Scott’s Emulsion capsules contain cod liver oil, DHA, EPA, vitamin A, 
vitamin D and calcium (Scott’s). The researchers asked teachers at the school to refer learners 
known to have an ADHD diagnosis based on information in school files to the study (Beart & 
Lessing, 2013). The participants selected were included based on the criteria of being primary 
school learners at this particular school and having an ADHD diagnosis. In addition to the 
children included in the study, three teachers and 11 parents agreed to take part. The researchers 
gave assessments before and after the yoga intervention. At both times in the study, children 
completed the Children’s Apperception Test (CAT) and the Lawrence Self-Esteem 
Questionnaire (LAWSEQ). The researchers also conducted parent-rated questionnaires, teacher-
rated questionnaires, and semi-structured interviews with parents, teachers and children. After 
being tape-recorded and transcribed, interviews were used for interpretations of the participants. 
The yoga program used in the study was created by a yoga instructor, and it was specifically 
created for children with ADHD. Participants attended 40 minute yoga classes twice a week for 6 
weeks. There were yoga postures specifically for each of the ADHD symptoms addressed by the 
study; anxiety, concentration, aggression and self-esteem. Most of the postures used in the 
intervention were animal-inspired since animals are typically of interest to children. A chart from 
Beart & Lessing (2013), these poses included “The Eagle” for concentration, “The Crocodile” 
for aggression, “The Dragonfly” for anxiety and “The Lion” for self-esteem (p. 41). The 
researchers analyzed the data gathered through organizing details about the case, categorizing the 
data, interpreting unique instances, finding patterns, synthesizing and discerning trends. This 
process was based on two prior studies. Overall, parent and teacher perceptions were that the 
yoga intervention aided in improvement of the four ADHD symptoms examined in the study. 
After the intervention, parents of only participants A and D reported no change, parents of 
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participant F indicated that concentration did not improve, the teachers of participant C reported 
that the participant lacked concentration and teachers of participant J reported that the participant 
was still impulsive. While the teachers of participant C reported that the participant lacked 
concentration, the parents of the same participant reported more focus on homework. At the 
beginning of the study, it was reported that learner participants did not demonstrate great 
concentration at either home or school. However, after the yoga intervention, many participants 
made statements indicating concentration improved. Comments that Beart and Lessing (2013) 
received included a comment from the parent of participant C that “His homework that he’s been 
bringing home is much better, so the time we have taken for homework has been quicker and 
he’s done things properly and there have been fewer corrections” (p. 44). High rates of 
frustration were shown in parent and teacher responses before the yoga intervention, and a few 
positive comments related to aggression were collected after the intervention. Before the yoga 
intervention, there were varying levels of anxiety in the learner participants, and after the 
intervention, anxiety-related aspects were found less frequently. For example, Beart and Lessing 
(2013) state that the parent of participant H reported “He’s (H) been sleeping through lately” (p. 
45). It was found at the beginning of the study that self-esteem of the learner participants was not 
constant, and it particularly negatively affected when a situation involved academic capabilities. 
Four participants were shown to have better self-esteem after the intervention according to the 
LAWSEQ. Beart and Lessing (2013) report that participant C is one of the participants who 
showed increased self-esteem, and participant C said “Usually I felt left out because even when I 
am chosen in something it’s lit I won’t pass or anything, but when the yoga was finished it’s like 
I touched the goal a lot of times” (p. 45). The information this case study found aligns with prior 
research. This particular study does not predict the long-term impacts of yoga, but it can 
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reasonably suggest that a specialized yoga program can positively impact concentration, 
aggression, anxiety and self-esteem in children with ADHD. 
 
Results 
 The purpose of this literature review was to examine the effectiveness of a selection of 
interventions for ADHD other than or in addition to medication. Factors involved in the 
interventions Omega-3 supplements, specific diets, and yoga were reviewed. Studies were 
reviewed for each of the three interventions to examine which interventions most consistently 
contribute to positive outcomes in children with ADHD. The countries represented in the study 
and how many studies took place in each country represented are shown in Table 2. 
Omega-3 Fatty Acids 
 One of the interventions for ADHD reviewed was omega-3 fatty acids. Factors such as 
age and whether medication was allowed during the intervention varied. 
Participants. The lowest number of participants in a study on the effects of omega-3 
fatty acids in children with ADHD was 48 (Crippa et al., 2018), and the highest number was 162 
(Cornu et al., 2018). The other studies had 54-57 (Milte et al., 2015), 67 (Milte et al., 2012), and 
90 (Barragán, et al., 2017) participants. The age ranges in the five studies reviewed regarding 
omega-3 fatty acids were very similar. The age ranges were 6-12 (Barragán, et al., 2017), 6-15 
(Cornu et al., 2018), 6-13 (Milte et al., 2015), 7-12 (Milte et al., 2012) and 7-14 (Crippa et al., 
2018) years old. Therefore, all of the participants were school-aged. Three of the studies required 
that participants have an ADHD diagnosis (Cornu et al., 2018; Crippa et al., 2018; Barragán et 
al., 2017). Two studies require that participants have either an ADHD diagnosis or symptoms 
greater than the 90th percentile on the CPRS (Milte et al., 2012; Milte et al., 2015). Only one of 
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the five studies allowed participants to take ADHD medication during the intervention, and in 
that study, medication was part of two of the interventions (Barragán, et al., 2017).  
Setting. One study took place in France, but a specific location of the intervention was 
not stated as capsules were sent out with participants (Cornu et al., 2018). Children saw child 
psychiatrists for ADHD diagnoses. Another study took place in Mexico, but a specific location 
of the intervention was not indicated (Barragán, et al., 2017). The participants went through 
clinical assessments five times during the study. Both Milte et al. (2015) and Milte et al. (2012) 
were conducted in Australia. In the 2015 study by Milte et al., participants visited either the 
Nutritional Physiology Research Centre at the University of South Australia or the Institute of 
Health and Biomedical Innovation to have blood taken and complete cognitive assessments. 
Their parents turned in capsule containers at each visit so that the researchers could measure 
compliance, but it was not indicated where the participants took the capsules. Participants and 
parents also visited either the Nutritional Physiology Research Centre at the University of South 
Australia or the Institute of Health and Biomedical Innovation in the 2012 study by Crippa et al., 
but they only visited two times in this study. Similar to the more recent study, participants had 
blood taken and completed cognitive assessments at each visits. Capsule containers were 
collected at the second of the two visits to measure compliance, but where the participants took 
the capsules was not stated. The study by Crippa et al. (2018) was conducted in Italy, and 
participants were observed and assessed by a child psychologist to have their ADHD diagnoses 
confirmed. Participants visited the Child Psychopathology Unit at Scientific Institute ICCRS E. 
Medea three times during the study, and at these visits they had clinical measurements completed 
and participated in cognitive tests while parents and investigators completed behavioral and 
clinical scales. Blood was taken at the children’s first visit to the unit. The setting of the 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               40 
intervention itself was not indicated as parents of the participants took the supplements from the 
researchers. The countries in which all of the interventions for each type of intervention can be 
seen in Table 2. 
Length of intervention. The lengths of the interventions in the studies reviewed ranged 
from 3 months to 12 months. Two study interventions lasted 12 months (Barragán, et al., 2017; 
Milte et al., 2015), one study intervention lasted 6 months (Crippa et al., 2018), one lasted four 
months (Milte et al., 2012), and one lasted 3 months (Cornu et al., 2018).  
Effectiveness. For the purposes of this research study, a particular intervention was 
determined to be effective if there was significant improvement in ADHD symptoms in the child 
from baseline at the conclusion of the intervention. A study was considered effective if the 
differences shown through the measures used in the particular study had a p-value of ≤.05. Two 
of the five studies reviewed on omega-3 fatty acids showed that this intervention can have 
significant positive impacts on children with ADHD (Barragán et al., 2017; Milte et al., 2015). 
The other three studies on this intervention did not show significant influence of omega-3 fatty 
acids on children with ADHD (Cornu et al., 2018; Crippa et al., 2018; Milte et al., 2012). 
Effectiveness for these five studies did not consider qualitative data, only statistical significance 
of the outcomes of the intervention. 
Studies found to be effective. One of the studies on omega-3 fatty acids that were found 
to have a significant impact on children with ADHD required an ADHD diagnosis for children to 
participate in the study (Barragán et al., 2017), and the other required a diagnosis or symptoms 
greater than the 90th percentile on the CPRS (Milte et al., 2015). One study did not allow 
participants to take ADHD medication (Milte et al., 2018), and the other study included ADHD 
medication as part of the interventions examined (Barragán et al., 2017). The studies were 
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conducted in two different countries on two different continents. Barragán et al. (2017) was 
conducted in Mexico, and Milte et al. (2015) was conducted in Australia. The number of 
participants in each study varied as one had 90 participants (Barragán et al., 2017) and the other 
had 54-57 participants (Milte et al., 2015). One of the studies involved an institute that treats 
patients in finding participants. Participants in the Barragán et al. (2017) study were referred to 
the Neurology Department of the Hospital Infantil de México Federico Gómez. The two studies 
had similar age ranges for participants, as the participants were 6-12 (Barragán et al., 2017) and 
6-13 (Milte et al., 2015). Both of the studies lasted 12 months (Barragán et al., 2017; Milte et al., 
2015).  
Diet and Nutrition 
 Another intervention reviewed was diet and nutrition. Studies on various aspects of diet 
and nutrition were included in the current study. One study reviewed examined artificial food 
colorings and a preservative (Lok et al., 2013). Another study researched whether healthy and 
unhealthy foods have an impact on children with ADHD (Ghanizadeh & Haddad, 2015). One 
study examined the effects of a restricted elimination diet (Pelsser et al., 2011), one study 
focused on vitamin-mineral treatment (Rucklidge et al., 2018), and one study researched how 
children’s dietary and nutrient patterns can be associated with ADHD (Zhou et al., 2016).  
Participants. The range of the number of participants in the studies reviewed that 
involved diet and nutrition of participants was very high. The number of participants ranged 
from 83 (Pelsser et al., 2011) to 592 (Zhou et al., 2016) The other studies had 85 participants 
(Ghanizadeh & Haddad, 2015), 93 participants (Rucklidge et al., 2018) and 130 participants 
(Lok et al., 2013). There was more variance in the age ranges of the participants in the five 
studies on diet than in the five studies on omega-3 fatty acids. The age ranges for the studies on 
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diet and nutrition were 4-8 (Pelsser et al., 2011), 8-9 (Lok et al., 2013), 5-14 (Ghanizadeh & 
Haddad, 2015), 6-14 (Zhou et al., 2016) and 7-12 (Rucklidge et al., 2018). Two studies did not 
allow the participants to take ADHD medication (Lok et al., 2013; Pelsser et al., 2011). One 
study allowed participants to take medication (Rucklidge et al., 2018), as long as the dose 
remained constant the entire study. Another study had all of the participants take ADHD 
medication as part of the intervention (Ghanizadeh & Haddad, 2015). One study did not state 
whether participants could take ADHD medication while participating in the intervention (Zhou 
et al., 2016). Three of the studies required an ADHD diagnosis to participate (Ghanizadeh & 
Haddad, 2015; Pelsser et al., 2011; Zhou et al., 2016). Rucklidge et al. (2018) required that 
participants meet ADHD criteria on the K-SADS-PL and the CRS-R:L. Lok et al. (2013) did not 
state whether an ADHD diagnosis was required, but the article did state that the study was 
focused on how food additives and preservatives influence behavior in general rather than how 
they influence ADHD in children while using measurement methods often used in research on 
ADHD. 
Setting. The study by Lok et al. (2013) took place in China, and participants were 
recruited from schools in each of the three districts of Hong Kong to allow for socioeconomic 
diversity. An initial appointment was held with each participant at the Centre for Nutritional 
Studies. Researchers provided the three types of capsules for the participants, and the 
participants were to take the capsules before going to school. Ghanizadeh & Haddad (2015) 
conducted their study in Iran. The researchers involved face-to-face interviews in ADHD 
diagnoses, but the intervention occurred away from the researchers as parents were provided lists 
of foods. The study by Pelsser et al. (2011) was conducted in the Netherlands. A specific setting 
of the intervention was not specified as the intervention involved the participants’ full-time diets. 
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Rucklidge et al. (2018) carried out their study in New Zealand. The parents of participants were 
given the capsules that the participants was to take, and where the participants took the capsules 
was not specified. Every 2 weeks, participants had in-person visits to be monitored, and there 
was a total of six in-person visits. The visits were with a clinical psychologist or a psychology 
graduate student who was supervised by a psychologist. The study by Zhou et al. (2016), which 
was conducted in China, did not have an intervention. Children’s diets in their normal settings 
were considered as parents responded to an FFQ about their child’s diet over the past year, and 
parents were interviewed in person by researchers. The children were seen in person when they 
had blood samples taken. 
Length of intervention. All of the interventions for studies focusing on diet and nutrition 
were shorter than all of the interventions used in the studies reviewed on omega-3 fatty acid 
interventions. The shortest diet intervention reviewed was one month (Ghanizadeh & Haddad, 
2015), and the longest was 10 weeks (Rucklidge et al., 2018). The other studies were 5 weeks 
(Pelsser et al., 2011) and 6 weeks (Lok et al., 2013). One study examined the normal dietary 
patterns of participants and therefore did not have an intervention (Zhou et al., 2016). 
Effectiveness. As with the omega-3 fatty acid studies, a particular intervention or dietary 
pattern was determined to be effective if there was significant improvement in ADHD symptoms 
in the child from baseline at the conclusion of the intervention or evaluation of normal dietary 
patterns, and a study was considered effective if the differences shown had a p-value of ≤.05. 
Qualitative data was not considered for any of the studies reviwed on diet and nutrition. Two of 
the diet and nutrition studies reviewed showed significant positive impacts on ADHD symptoms 
in children (Pelsser et al., 2011; Zhou et al., 2016), and three of the studies reviewed did not 
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show significant positive impacts (Lok et al., 2013; Ghanizadeh & Haddad, 2015; Rucklidge et 
al., 2018).  
Studies found to be effective. One of the studies found to be effective required 
participants to have an ADHD diagnosis (Pelsser et al., 2011). The other study found to be 
effective was a matched case-control study, so only the participants in the ADHD group were 
required to have an ADHD diagnosis. The number of the participants in the two studies had a 
large difference, as one study had 83 participants (Pelsser et al., 2011), and the other had 592 
participants including those in both the ADHD group and the non-ADHD control group (Zhou et 
al., 2016). The age ranges of the participants in these two studies had very little overlap. The age 
ranges were 4-8 (Pelsser et al., 2011) and 6-14 (Zhou et al., 2016). Participants in the study by 
Pelsser et al. (2011) were not allowed to take ADHD medication during the study, and it is not 
stated whether participants in the study by Zhou et al. (2016) could. One study took place in the 
Netherlands (Pelsser et al., 2011), and the other took place in China (Zhou et al., 2016). The 
intervention of the study by Pelsser et al. (2011) lasted 5 weeks. The study by Zhou et al. (2016) 
did not have an intervention because the researchers gathered information on participants’ 
normal diets and examined the blood samples taken from the participants.  
Yoga 
 Five articles were also reviewed on the effectiveness yoga can have on children with 
ADHD. The interventions in the articles reviewed varied in multiple ways. 
Participants. The number of participants in the studies reviewed on yoga varied. Two 
studies had very few participants, with one having nine (Hariprasad et al., 2013), and the other 
having 10 (Beart & Lessing, 2013). One study had 23 participants (Cohen et al., 2018), one had 
50 participants (Chou & Huang, 2017), and one had 63 participants (Mehta et al., 2011). Four of 
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the studies had similar age ranges of participants, and one had a younger sample. The younger 
sample was a preschool-aged group, with participants ages 3 to 5 (Cohen et al., 2018). The other 
studies had school-aged children with the age ranges of 9 to 10 (Beart & Lessing, 2013), 8 to 12 
(Chou & Huang, 2017), 6 to 13 (Hariprasad et al., 2013) and 6 to 11 (Mehta et al., 2011). Four of 
the studies on yoga required that participants have an ADHD diagnosis (Beart & Lessing, 2013; 
Chou & Huang, 2017; Hariprasad et al., 2013; Mehta et al., 2011). The other study required that 
the participants demonstrate at least four symptoms on the ADHD-RS-IV instead of a diagnosis 
as ADHD is not typically diagnosed in preschoolers, who made up the sample of the study 
(Cohen et al., 2018). Three studies allowed the participants to take ADHD medication during the 
intervention (Beart & Lessing, 2013; Cohen et al., 2018; Hariprasad et al., 2013). One study 
allowed participants to take medication during part of the study, but paticipants were told to not 
take medications for at least 24 hours before various tests within the study (Chou & Huang, 
2017). One study did not state whether participants were allowed to take medication during the 
intervention. 
Setting. One study took place in Taiwan, and the yoga intervention took place in a dance 
studio (Chou & Huang, 2017). The yoga classes were led by a nationally certified yoga 
instructor. Whether participants were part of the yoga group depended on their school district. 
The participants and parents went to the laboratory of the researchers twice to complete pre- and 
post-tests of the Visual Pursuit Test and the Determination Test. The study by Mehta et al. 
(2011) was conducted in India, and the yoga intervention took place as part of the regular school 
day. It was not stated where the Vanderbilt questionnaires were completed. Cohen et al. (2018) 
carried out their study in California. The yoga intervention in this study was conducted at both 
home and school. At home, participants followed a yoga DVD and their parents encouraged 
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them. At the urban, community-based preschool, participants completed two 30-minute group 
yoga sessions led by trained children’s yoga instructors per week. One group had yoga sessions 
outside of their normal classroom, and the other group had in-classroom yoga sessions that 
included typically developing peers completing the session and teachers helping to manage the 
class. Setting of assessments was not specified. India was also the country in which the study by 
Hariprasad et al. (2013) was conducted. The yoga intervention was first done with participants in 
the hospital they were in, and when they were discharged, caregivers were to supervise or do 
yoga with the participants at home. The yoga instructor rated the participants’ yoga abilities at 
the hospital, and it is not stated whether researchers and caregivers met in person to complete 
measurements related to ADHD. Beart and Lessings’ 2013 study took place in South Africa. The 
yoga intervention, in the form of 40-minute classes twice a week for 6 weeks, was conducted in a 
school for children with learning difficulties. The program for the classes was created by a yoga 
instructor. As the researchers state that the study, not the intervention, took place in this 
particular school, it is possible that the assessments used in the study were also completed at the 
school. 
Length of intervention. All of the yoga interventions were shorter than all of the omega-
3 fatty acid interventions. The lengths of the majority of the yoga interventions were similar to 
the lengths of the diet and nutrition interventions. The shortest yoga intervention had a minimum 
of eight days of yoga practice (Hariprasad et al., 2013). The longest intervention lasted 12 weeks 
(Cohen et al., 2018). One intervention lasted 8 weeks (Chou & Huang, 2017), and two 
interventions lasted 6 weeks (Beart & Lessing, 2013; Mehta et al., 2011).  
Effectiveness. Similar to the omega-3 fatty acid and diet and nutrition studies, a 
particular yoga intervention was determined to be effective if there was significant improvement 
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in ADHD symptoms in the child from baseline at the conclusion of the intervention. Quantitative 
studies were considered effective if the differences shown had a p-value of ≤.05. One 
quantitative study on a yoga intervention was reviewed (Beart & Lessing, 2013). To determine 
whether this study was effective, trends and global statements about yoga were examined. All 
five of the yoga interventions reviewed were found to be effective (Beart & Lessing, 2013; Chou 
& Huang, 2017; Cohen et al., 2018; Hariprasad et al., 2013; Mehta et al., 2011). Cohen et al. 
(2018) had one scale that did showed a significant effect for the undesired outcome, but another 
scale showed significant effects for desired outcomes. 
Studies found to be effective. As demonstrated in previous paragraphs, all of the 
examined aspects of the studies reviewed had variance. While four of the studies had school-
aged participants, these age ranges varied (Beart & Lessing, 2013; Chou & Huang, 2017; 
Hariprasad et al., 2013; Mehta et al., 2011). The studies were also split on whether participants 
were allowed to take medication during the yoga interventions and whether participants needed 
an official ADHD diagnosis to participate in the study. The intervention lengths ranged from 
eight days to 12 weeks. Quantitative data was used to determine that Chou & Huang (2017), 
Cohen et al. (2018), Hariprasad et al. (2013) and Mehta et al. (2011) had significant positive 
impacts on ADHD symptoms in children. Participants in the study by Chou & Huang (2017) 
who were in the yoga group showed significantly better accuracy and reaction time than the 
control group on both the Visual Pursuit Test (p=.010; p<.001) and the Determination Test 
(p<.001; p=.034) at the post-test. These differences in the post-tests were shown despite no group 
differences found at the pre-test for each test. Mehta et al. (2011) found that participants showed 
a significant decline (p<.001) in average performance impairment on the teacher and parent 
Vanderbilt assessments after completing the yoga intervention. In the study by Cohen et al. 
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(2018), it was found that the group who completed the yoga intervention first showed lower 
scores than the group who had not completed the intervention yet. Participants in the first group 
to complete yoga who started at SDQ hyperactive-inattentive scale scores of 8.5 had, on average, 
scores two points lower than children in the second group to complete yoga who started at this 
score (p=.04), and participants in the first group who started at a score of 17 on ADHD 
inattention ratings had scores, on average, four points lower than participants in the second group 
to complete the intervention (p=.02). Furthermore, total scores on the SDQ decreased 
significantly after the second group to participate in yoga completed the intervention (p=.002). 
The Cohen et al. (2018) study did include one finding that does not support yoga as an 
intervention for ADHD. The study found that scores on the ADHD-RS-IV for the group that 
completed yoga second increased (p=.03). Hariprasad et al. (2015) found significant decreases in 
scores on the CARS (p=.014), the ADHD-RS-IV (p=.021), and the CGI (p=.004) from baseline 
to when the participants were discharged from the adolescent psychiatry ward of the National 
Institute of Mental Health and Neurosciences after completing a yoga intervention. The study by 
Beart & Lessing was a qualitative study. The CAT results they found suggested that anxiety-
related issues could have lowered after the yoga intervention, and the LAWSEQ showed that 
four participants had improved self-esteem after the yoga intervention. There were also trends of 
improved concentration and less aggression.  
Discussion 
 The goal of the current study was to find ADHD interventions that could be used as 
alternatives to medication or in conjunction with medication, which is currently the most 
common treatment for ADHD (De Sousa & Kalra, 2012). Stimulants are currently the most 
common medication used for ADHD, and they have many side effects (National Institute of 
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Mental Health, 2016; Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering 
Committee on Quality Improvement and Management, 2011). The current study also had a goal 
to research interventions that could be implemented or done in schools to encourage focus and 
decrease hyperactivity in children with ADHD during the school day. Of the three types of 
interventions studied in this literature review, yoga was the most consistently effective 
intervention, as all five of the yoga interventions reviewed had significant positive effects on 
ADHD symptoms in children with ADHD. Of the five omega-3 fatty acid interventions reviewed 
and the five diet and nutrition interventions reviewed, only two out of the five studies for each 
type of intervention were found to have significant positive effects on ADHD symptoms in 
children with ADHD. Furthermore, of the five yoga interventions reviewed, three involved yoga 
sessions at the participants’ schools. No studies reviewed for diet and nutrition reported 
interventions that took place at the participants’ schools despite the plausibility of schools 
incorporating foods that positively impact ADHD symptoms into cafeteria menus. 
Limitations 
Limitations of the study include the small number of recent studies on the effects of diets 
excluding food additives such as artificial food coloring in children with ADHD. Multiple search 
terms were used in searching for such articles. Many more studies on these interventions in 
addition to those included in the current review exist, but the current review focused on articles 
written between 2011 and 2018. 
Another limitation of the study is that not all studies reviewed carried out their 
interventions in school settings. The feasibility of carrying out interventions for ADHD that do 
not involve medication in schools is of interest to the study. Furthermore, not all interventions of 
the studies reviewed carried out interventions in multiple settings, such as the children’s homes 
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and schools. Interventions that can reasonably be implemented in multiple settings are important 
since children diagnosed with ADHD experience ADHD symptoms in multiple settings 
(American Psychiatric Association, 2013). 
Additionally, the age of the participants in each study reviewed varied. Currently, there is 
a lack of information about the generalizability of the three types of interventions studied here 
varies across age groups. This gap in the literature provides direction for future research. For 
example, future studies could examine the age ranges for which each intervention is the most 
effective. 
The studies were conducted in various countries. More studies for each intervention in 
each country would provide more information to prove whether or not the interventions are 
effective and generalizable. 
Some studies reviewed excluded children currently taking ADHD medication while 
others allowed children to take medication during the interventions. For this reason, the present 
study examined ADHD interventions that can serve as alternatives or as supplements to medical 
intervention. 
Implications 
Based on the studies reviewed, yoga has potential to be an effective intervention for 
ADHD in multiple settings. Three studies took place in schools (Beart & Lessing, 2013; Cohen 
et al., 2018; Mehta et al., 2011) and demonstrated that yoga can be done in schools. The study by 
Hariprasad et al. (2015) demonstrated that yoga can be an effective ADHD intervention also for 
children in hospitals. If parents do not want their children to participate in yoga, they could 
consider giving their children omega-3 fatty acid supplements as an intervention for ADHD. It 
should be acknowledged, though, that only two of the studies reviewed on omega-3 fatty acids 
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showed them to be effective (Barragán et al., 2017; Milte et al., 2015). Parents could also 
consider feeding their children based on a restricted elimination diet (Pelsser et al., 2011) or 
feeding fish and white meat (Zhou et al., 2016).  
The studies reviewed on the impacts of yoga on ADHD symptoms in children suggest 
that yoga is a plausible intervention for ADHD in schools. As stated earlier, three yoga 
intervention studies reviewed involved participants practicing yoga in the schools as the 
intervention. Cohen et al. (2018) showed positive impacts of yoga sessions with a trained 
instructor on preschoolers. The results were most significant for children with higher ADHD 
ratings at baseline data. The yoga intervention occurred both in and out of the normal classroom, 
depending on the group. Mehta et al. (2011) implemented yoga in schools using high school 
student volunteers to lead the yoga sessions after being trained. The researchers determined that 
the program was implemented successfully, and by the fifth week of the intervention, student 
volunteers from the school fully managed the program. The researchers therefore suggest that 
yoga can be an effective method of improving symptoms in children with ADHD at little cost to 
the school. To maintain a low cost of the program, however, facilitators would need to be able to 
be trained quickly. Low costs of an intervention could make it more appealing to schools, and the 
ability of volunteer high school students to run a yoga program suggests that school personnel 
could be trained to run such programs as well. To successfully implement yoga in schools 
through school personnel, teachers and counselors should receive training on the benefits and 
how to lead yoga during their professional training in order to be accepting of the idea of using 
time for yoga. While Chou and Huang (2017) did not conduct their intervention in a school, they 
recommend yoga to schools as a curriculum or extra-curriculum based on certain ADHD-related 
cognitive functions being shown to be positively influenced by yoga. The study by Beart and 
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Lessing (2013), which took place in a school for children with learning disabilities, showed 
positive impacts of yoga on the participants. 
Future Research 
In this review, yoga was found to be the most effective intervention for ADHD instead of 
or in conjunction with medication compared to omega-3 fatty acids and diet and nutrition. There 
are factors that need to be considered in future studies on yoga as an intervention for ADHD. 
There are also factors in studies on omega-3 fatty acids and diet and nutrition as ADHD 
interventions that need to be considered in future studies.  
Number of participants. Future studies on yoga as an intervention for ADHD symptoms 
in children need to include more participants. The highest number of participants in the studies 
on yoga interventions used was 63 participants (Mehta et al., 2011). The study by Beart & 
Lessing included 10 participants, and the study by Hariprasad et al. (2013) included nine 
participants. Both of the studies acknowledged that their findings could not be generalized due to 
the small sample sizes. Cohen et al. (2018), which had 23 participants, cited their sample size as 
a limitation since this number is lower than the sample size they wanted based on power 
calculations. Therefore, future studies need to include enough participants to allow for 
generalizability of the effect of yoga interventions on ADHD symptoms for children of various 
ages. A few of the studies on omega-3 fatty acids could have benefited from more participants. 
The lowest numbers of participants in these studies was 48 (Crippa et al., 2018) and 54-57 (Milte 
et al., 2015). Crippa et al. (2018) cited sample size as a limitation, and the researchers said that 
about 330 participants would need to be recruited in order for the effect of omega-3 fatty acid 
supplements to be reliably found.  
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Length of study. As stated in Beart and Lessing (2013), future studies on yoga should 
have longer interventions to determine whether children with ADHD can be influenced by yoga 
long-term. This study suggests that a yoga intervention should last at least 6 months to examine 
long-term effects. The longest yoga intervention included in the present literature review was 12 
weeks (Cohen et al., 2018), and it was part of the most recent study included on yoga. It is 
encouraging that there has been a study on the impacts of yoga on ADHD symptoms that was 
approximately 3 months, but studies on such interventions still need to be longer. Furthermore, 
even the researchers for study with the longest intervention review cited a short intervention 
period as a limitation (Cohen et al., 2018). The longest intervention found involving school-aged 
children who had ADHD diagnoses was 8 weeks. Therefore, studies with longer yoga 
interventions for school-aged children especially need to be conducted. Longer studies are 
needed to research the consistency of the effectiveness of omega-3 fatty acids. The longest 
studies reviewed were both 12 months (Mitle et al., 2011; Milte et al., 2015) and both of these 
studies were found to be effective. The other studies ranged from 3 months (Cornu et al., 2018) 
to 6 months (Crippa et al., 2018), and none of these studies were found to be effective. More 
studies should be conducted that involve interventions that last at least 12 months to see if 
omega-3 fatty acids are consistently effective as an intervention for ADHD after this amount of 
time. Longer studies on diet and nutrition as an intervention for ADHD are needed as well. The 
studies on diet and nutrition reviewed included an intervention as short as one month 
(Ghanizadeh & Haddad, 2015), and the longest intervention lasted only 10 weeks (Rucklidge et 
al., 2018). One intervention was effective despite lasting 5 weeks (Pelsser et al., 2011), but it is 
possible that more of the interventions could have been effective if they had lasted longer. 
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Interventions that last longer are needed to examine the long-term effects of both omega-3 fatty 
acids and various diets and nutrition on ADHD symptoms. 
Symptoms. Future studies should examine whether certain interventions are more 
effective depending on the ADHD symptoms demonstrated. As there have been gender 
differences found in the presentations of ADHD (Zambo, 2008), future studies should examine 
whether boys and girls respond differently to the interventions. Setting is a part of ADHD 
diagnosis (American Psychiatric Association, 2013), so it should be studied whether the 
effectiveness interventions have on ADHD symptoms vary across settings. 
Conclusion 
In conclusion, yoga interventions that were part of studies reviewed for this literature 
review were found consistently to have significantly positive aspects. Based on the interventions 
themselves and researcher evaluations, yoga is a plausible option for schools implementing 
ADHD interventions because of potential for low costs and facilitation by school personnel. 
More studies need to be conducted to determine generalizability by involving more participants 
and long-term impacts through conducting longer interventions. More studies also need to be 
conducted to examine the effectiveness of omega-3 fatty acids and diet and nutrition as ADHD 
interventions so that parents and caregivers can explore these options. 
 
 
  
  
 
 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               55 
References 
American Academy of Pediatrics. (2016). Non-stimulant medications available for ADHD.  
 
Retrieved from https://www.healthychildren.org/English/health- 
 
issues/conditions/adhd/Pages/Non-Stimulant-Medications-Available-for-ADHD- 
 
Treatment.aspx 
 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition. Arlington, VA, American Psychiatric Association, 2013. 
Association for Behavioral and Cognitive Therapies. ABCT Fact Sheets: 
Attention-Deficit/Hyperactivity Disorder. Retrieved from 
http://www.abct.org/docs/factsheets/ADHD.pdf 
Banaschewski, T., Roessner, V., Dittmann, R. W., Santosh, P. J., & Rothenberger, A. (2004).  
 
Non-stimulant medications in the treatment of ADHD. European Child & Adolescent  
 
Psychiatry, 13(1), i102-i116). doi: 10.1007/s00787-004-1010-x  
 
Barragán, E., Breuer, D., & Döpfner, M. (2017). Efficacy and safety of omega-3/6 fatty acids, 
  
methylphenidate, and a combined treatment in children with ADHD. Journal of Attention 
  
Disorders, 21(5), 433-441. doi: 10.1177/1087054713518239 
  
Black, J. L. & Bruce, B.K. (1989). Behavior Therapy: A Clinical Update. Hospital and 
  
Community Psychiatry, 40 (11), 1152-1158. Retrieved from 
  
https://ps.psychiatryonline.org/doi/pdf/10.1176/ps.40.11.1152 
  
Castle, L., Aubert, R. E., Verbrugge, R. R., Khalid, M., & Epstein, R. S. (2007). Trends in 
  
medication treatment for ADHD. Journal of attention disorders, 10(4), 335-342. 
 
Centers for Disease Control and Prevention. (2017). Attention-Deficit/Hyperactivity Disorder  
 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               56 
(ADHD): Basic Information. Retrieved from  
 
https://www.cdc.gov/ncbddd/adhd/facts.html  
 
Centers for Disease Control and Prevention. (2017). Attention-Deficit/Hyperactivity Disorder  
 
(ADHD): Behavior therapy for young children with ADHD. Retrieved from  
 
https://www.cdc.gov/ncbddd/adhd/behavior-therapy.html 
 
Centers for Disease Control and Prevention. (2017). Attention-Deficit/Hyperactivity Disorder 
  
(ADHD): Symptoms and diagnosis. Retrieved from 
  
https://www.cdc.gov/ncbddd/adhd/diagnosis.html  
 
Centers for Disease Control and Prevention. (2017). Attention-Deficit/Hyperactivity Disorder  
 
(ADHD): Treatment. Retrieved from https://www.cdc.gov/ncbddd/adhd/treatment.html 
 
Centers for Disease Control and Prevention. (2005). Mental health in the United States:  
 
Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity  
 
disorder--United States, 2003. Morbidity and Mortality Weekly Report, 54(34), 842-847.  
 
Retrieved from  
 
http://vb3lk7eb4t.scholar.serialssolutions.com/?sid=google&aulast=Centers+for+Disease 
  
+Control+and+Prevention+(CDC&atitle=Mental+health+in+the+United+States.+Prevale 
  
nce+of+diagnosis+and+medication+treatment+for+attention-deficit/hyperactivity+disord 
  
er--United+States,+2003.&id=pmid:16138075 
  
CHADD. (2018). The ADHD Diagnostic Process. Retrieved from 
  
http://www.easybib.com/reference/guide/apa/website 
  
CHADD. (2018). Diagnosis in Children. Retrieved from http://www.chadd.org/Understanding- 
  
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               57 
ADHD/For-Professionals/For-Healthcare-Professionals/The-ADHD-Diagnostic- 
  
Process/Diagnosis-in-Children.aspx 
  
Chou, C., & Huang, C. (2017). Effects of an 8-week yoga program on sustained attention  
 
and discrimination function in children with attention deficit hyperactivity disorder.  
 
PeerJ, 5(1), e2883. 10.7717/peerj.2883 
  
Cohen, S. C. L., Harvey, D. J., Shields, R. H., Shields, G. S., Rashedi, R. N., Tancredi, D. J., 
  
Angkustsiri, K., Hansen, R. L., & Schweitzer, J. B. (2018). Effects of yoga on attention, 
  
impulsivity, and hyperactivity in preschool-aged children with Attention-Deficit 
  
Hyperactivity Disorder symptoms. Journal of Developmental and Behavioral Pediatrics, 
  
39(3), 200-209. doi: 10.1097/DBP.0000000000000552 
  
Cornu, C., Mercier, C., Ginhoux, T., Masson, S., Mouchet, J., Nony, P., Kassai, B., Laudy, V., 
  
Berquin, P., Franc, N., Le Heuzey, M., Desombre, H., & Revol, O. (2018). A double- 
 
blind placebo-controlled randomised trial of omega-3 supplementation in children with 
  
moderate ADHD symptoms. European Child & Adolescent Psychiatry, 27(3), 377-384. 
  
doi: 10.1007/s00787-017-1058-z 
 
DailyMed. (2018). KAPVAY-clonidine hydrochloride tablet, extended release. NIH U.S.  
 
National Library of Medicine. Retrieved from  
 
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa7700e2-ae5d-44c4-a609- 
 
76de19c705a7 
 
De Sousa, A. & Kalra, G. (2012). Drug therapy of attention deficit hyperactivity disorder:  
 
Current trends. Mens Sana Monographs, 10(1). doi: 10.4103/0973-1229.87261 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               58 
  
Dukes, R. L., Stein, J. A., & Zane, J. I. (2010). Gender differences in the relative impact of 
physical and relational bullying on adolescent injury and weapon carrying. Journal of 
School Psychology, 48(6), 511-532. doi: 10.1016/j.jsp.2010.08.001 
DuPaul, G. J., Power, T. J., Anastopoulos, A. D., & Reid, R. (1998). ADHD Rating Scale-IV: 
  
Checklists, norms, and clinical interpretation. New York, NY: Guilford Press. 
Eye q. The natural approach to improving ADHD symptoms. Retrieved from http://eyeqsa.co.za/ 
Franks, C. M. & Wilson, G. T. (1975). Annual review of behavior therapy and practice (Vol. 3). 
New York, NY: Brunner/Mazel. 
Gaub, M. & Carlson, C. L. (1997). Gender differences in ADHD: A meta-analysis and critical 
  
review. Journal of the American Academy of Child and Adolescent Psychiatry, 36(8), 
  
1036-1045. doi: 10.1097/00004583-199708000-00011 
Gow, R. V., Hibbeln, J. R., & Parletta, N. (2015). Current evidence and future directions for 
research with omega-3 fatty acids and attention deficit hyperactivity disorder. Current 
Opinion in Clinical Nutrition and Metabolic Care, 18(2), 133-138. doi: 
10.1097/MCO.0000000000000140 
Hayes, S. C. (2016). Acceptance and commitment therapy, relational frame theory, and the 
third wave of behavioral and cognitive therapies–republished article. Behavior 
Therapy, 47(6), 869-885. doi: 10.1016/j.beth.2016.11.006 
Kelly, K. ADHD alternative treatment: What you need to know. Understood. Retreived from  
 
https://www.understood.org/en/learning-attention-issues/child-learning-disabilities/add- 
 
adhd/adhd-alternative-treatment-what-you-need-to-know 
 
 
 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               59 
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V.  
 
K., Gonzales, J., Malcolm, S. K., Schuh, K. J., & Allen, A. J. (2004). Once-daily  
 
atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including  
 
an assessment of evening and morning behavior: A double-blind, placebo-controlled trial.  
 
Pediatrics, 114(1). doi: 10.1542/peds.114.1.e1 
 
Lagerspetz, K., Björkqvist, K., & Peltonen, T. (1988). Is indirect aggression typical 
of females - gender differences in aggressiveness in 11-year-old to 12-year-old children. 
Aggressive Behavior, 14(6), 403-414. doi: 
10.1002/1098-2337(1988)14:6<403::AID-AB2480140602>3.0.CO;2-D 
Lok, K. Y. W., Chan, R. S. M., Lee, V. W. Y., Leung, P. W., Leung, C., Leung, J., & Woo, J. 
(2013). Food additives and behavior in 8- to 9-year-old children in hong kong: A 
randomized, double-blind, placebo-controlled trial. Journal of Developmental and 
Behavioral Pediatrics, 34(9), 642-650. doi:10.1097/DBP.0000000000000005 
Mehta, S., Mehta, V., Mehta, S., Shah, D., Motiwala, A., Vardhan, J., Mehta, N., & Mehta, D. 
  
(2011). Multimodal behavior program for ADHD incorporating yoga and implemented 
  
by high school volunteers: A pilot study. ISRN Pediatrics, 2011, 1-5. doi: 
  
10.5402/2011/780745 
 
Milte, C. M., Parletta, N., Buckley, J. D., Coates, A. M., Young, R. M., & Howe, P. R. C.  
 
(2012). Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children  
 
with attention-deficit/hyperactivity disorder: A randomized controlled trial. Nutrition, 28,  
 
670-677. doi: 10.1016/j.nut.2011.12.009  
  
Milte, C. M., Parletta, N., Buckley, J. D., Coates, A. M., Young, R. M., & Howe, P. R. C. 
 
(2015). Increased erythrocyte eicosapentaenoic  acid and docosahexaenoic acid are 
  
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               60 
associated with improved attention and behavior in children with ADHD in a randomized 
  
three-way crossover trial. Journal of Attention Disorders, 19(11), 954-964. doi: 
  
10.1177/1087054713510562 
 
National Institute of Mental Health. (2016). Attention deficit hyperactivity disorder. Retrieved  
 
from  
 
https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd/ind 
 
ex.shtml#part_145444 
 
National Institute on Drug Abuse. (2018). Prescription stimulants. Retrieved from  
 
https://www.drugabuse.gov/publications/drugfacts/prescription-stimulants 
 
National Survey of Children with Special Health Care Needs (Collected 2009-2010). [Map 
illustration of the percentages of children who received medication for ADHD in the past 
week and behavioral therapy in the past year by state]. Retrieved from 
https://www.cdc.gov/ncbddd/adhd/data-meds-behavioral.html 
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The 
worldwide prevalence of ADHD: A systematic review and metaregression analysis. The 
American Journal of Psychiatry, 164(6), 942-948. doi: 10.1176/ajp.2007.164.6.942 
Scott’s. Ask Scott’s. Retrieved from https://www.scottskids.com/sg/faq.html 
Shmygalev, S., Damm, M., Weckbecker, K., Berghaus, G., Petzke, F., & Sabatowski, R. (2011). 
  
The impact of long-term maintenance treatment with buprenorphine on complex 
  
psychomotor and cognitive function. Drug and Alcohol Dependence, 177(2-3), 190-170. 
  
doi: 10.1016/j.drugalcdep.2011.01.017 
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M.,  
Stevenson, J., Danckaerts, M., van der Oord, S., Döpfer, M., Dittman, R. W., Simonoff, 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               61 
E., Zuddas, A., Banaschewski, T., Buitelaar, J., Coghill, D., Hollis, C., Konofal, E.,  
Lecendreux, M., Wong, I. C. K., Sergeant, J., & European ADHD Guidelines Group.  
(2013). Nonpharmacological interventions for ADHD: Systematic review and  
meta-analyses of randomized controlled trials of dietary and psychological treatments.  
American Journal of Psychiatry, 170(3), 275-289. doi: 10.1176/appi.ajp.2012.12070991 
Sprich, S. E., Safren, S. A., Finkelstein, D., Remmert, J. E., & Hammerness, P. (2016). A 
randomized controlled trial of cognitive behavioral therapy for ADHD in 
medication- treated adolescents. Journal of Child Psychology and Psychiatry, 57(11). 
doi:1218-1226. 10.1111/jcpp.12549 
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality  
 
Improvement and Management (2011). ADHD: clinical practice guideline for the 
  
diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children 
  
and adolescents. Pediatrics, 128(5), 1007-1022. doi: 10.1542/peds.2011-2654 
  
Thapar, A. & Cooper, M. (2016). Attention deficit hyperactivity disorder. The Lancet, 
387(10024), 1240-1250. doi: 10.1016/S0140-6736(15)00238-X 
Unnever, J. D., & Cornell, D. G. (2003). Bullying, self-control, and adhd. Journal of 
Interpersonal Violence, 18(2), 129-147. doi:10.1177/0886260502238731 
The Understood Team (2016). At a glance: How ADHD medication works.  
 
https://www.understood.org/en/learning-attention-issues/treatments-approaches/medicati 
 
ons/at-a-glance-how-adhd-medication-works 
 
U. S. Food and Drug Administration (2017). Dealing with ADHD: What you need to know.  
 
Retreived from: https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm269188.htm 
 
 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               62 
Visser, S. N., Bitsko, R. H., Danielson, M. L., Gandhour, R., Blumberg, S. J., Schieve, L., 
Holbrook, J., Wolraich, M., & Cuffe, S. (2015). Treatment of 
attention-deficit/hyperactivity disorder among children with special health care needs. 
Journal of Pediatrics, 166(6), 1423-1430. doi: 10.1016/j.jpeds.2015.02.018 
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., 
Perou, R., & Blumberg, S. J. (2014). Trends in the Parent-Report of Health Care 
Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United 
States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry, 
53(1), 34-46. doi: 10.1016/j.jaac.2013.09.001 
 
Wernicke, J. F., Faries, D., Girod, D., Brown, J. W., Gao, H., Kelsey, D., Quintana, H., Lipetz,  
 
R., Michelson, D., & Heiligenstein, J. (2003). Cardiovascular effects of atomoxetine in  
 
children, adolescents, and adults. Drug Safety, 26(10), 729-740. doi: 0114-5916/03/0010- 
 
0729/$30.00/0    
 
Wigal, S. B. (2009). Efficacy and safety limitations of attention-deficit hyperactivity disorder  
 
pharmacotherapy in children and adults. CNS Drugs, 23(1), 21-31. doi: 1172- 
 
7047/09/0001-0021/$49.95/0  
 
Wood, J. G., Crager, J. L., Delap, C. M., & Heiskell, K. D. (2007). Literature review: Beyond  
 
methylphenidate, nonstimulant medications for youth with ADHD. Journal of Attention  
 
Disorders, 11(3), 341-350. doi: 10.1177/1087054707305968 
 
Zambo, D. (2008). Looking at ADHD through multiple lenses: Identifying girls with the 
inattentive type. Intervention in School and Clinic, 44(1), 34-40. doi: 
10.1177/1053451208318873 
  
 
 NONPHARMACOLOGICAL ADHD INTERVENTIONS                                               63 
 
 
 
 
 NON-MEDICATION ADHD INTERVENTIONS                                       
Research 
Article Intervention 
# of 
Participant
s 
Participant 
Age Range 
Allowed to 
take ADHD 
Medication 
Treatment 
Length Effective at the .05 Level 
Cornu et al. 
(2018) 
Omega-3 
Fatty Acids 162 6-15 No 3 Months No (p=.039 in favor of placebo) 
Barragán, et al. 
(2017) 
Omega-3 
Fatty Acids  90 6-12 Yes* 12 Months Yes (p=.007 in favor of combination) 
Milte et. al 
(2015) 
Omega-3 
Fatty Acids 54-57 6-13 No 12 Months 
Yes (p=.030 (ADHD Index n-3), p=.028 
(Conners Global n-3)) 
Milte et al. 
(2012) 
Omega-3 
Fatty Acids 67 6-13 No 4 Months 
No (p=.38 (EPA versus LA), p=.39 
(DHA versus LA) 
Crippa et al. 
(2018) 
Omega-3 
Fatty Acids 48 7-14 No 6 Months No (p>.05) 
Lok et al. 
(2013) Diet 130 8-9 No 6 Weeks 
No (Effect sizes: CBCL-TRF: .07 (A), 
.04 (B); SWANPT: .01 (A), .17 (B)) 
Ghanizadeh & 
Haddad (2015) Diet 85 5-14 Yes** 1 Month No (p=.2 during trial; p=.5 at end) 
Pelsser et al. 
(2011) Diet 83 4-8 No 5 Weeks Yes (p<00.0001 for ARS and ACS) 
Rucklidge et 
al. (2018) Diet 93 7-12 Yes 10 Weeks 
No (p=.415 for ADHD-RS-IV; p=.540 
for CPRS-R:L) 
Zhou et al. 
(2016) Diet 592 6-14 Not Stated No Intervention 
Yes (p=.003 Fish-white meat dietary 
pattern) 
Chou & Huang 
(2017) Yoga 50 8-12 Yes*** 8 Weeks Yes (p=.045, p<.05) 
Mehta et al. 
(2011) Yoga 63 6-11 Not Stated 6 Weeks Yes (p<.001) 
Cohen et al. 
(2018) Yoga 23 3-5 Not Stated 12 Weeks Yes (p=.02 ADHD RS-IV) 
Hariprasad et 
al. (2013) Yoga 9 6-13 Yes At least 8 Days Yes (p=.014, p=.021) 
Beart & 
Lessing (2013) Yoga 10 9-10 Yes 6 Weeks 
Case studies provide evidence to 
suggest yoga is beneficial 
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Table 1. Summary of articles reviewed 
*Part of study 
**Part of study; all had medication 
***Participants were told to not take medications for at least 24 hours before various tests within the study  
 
Country Omega-3 Fatty Acids 
Diet and 
Nutrition Yoga Total 
Australia 2   2 
China  2  2 
France 1   1 
India   2 2 
Iran  1  1 
Italy 1   1 
Mexico 1   1 
The Netherlands  1  1 
New Zealand  1  1 
South Africa   1 1 
Taiwan   1 1 
United States   1 1 
Table 2. Interventions reviewed by country 
 
